BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kazmierczak D, Jopek K, Sterzynska K, Ginter-Matuszewska B, Nowicki M, Rucinski M, Januchowski R. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines. Int J Mol Sci 2020;21:E2619. [PMID: 32283808 DOI: 10.3390/ijms21072619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Han S, Wang Z, Liu J, Wang HD, Yuan Q. miR-29a-3p-dependent COL3A1 and COL5A1 expression reduction assists sulforaphane to inhibit gastric cancer progression. Biochem Pharmacol 2021;188:114539. [PMID: 33819468 DOI: 10.1016/j.bcp.2021.114539] [Reference Citation Analysis]
2 Wang H. MicroRNAs and Apoptosis in Colorectal Cancer. Int J Mol Sci 2020;21:E5353. [PMID: 32731413 DOI: 10.3390/ijms21155353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wang H, Qi C, Wan D. MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition. Ann Transl Med 2021;9:124. [PMID: 33569426 DOI: 10.21037/atm-20-8027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li M, Zhang S, Ma Y, Yang Y, An R. Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer. Oncol Rep 2021;45:84. [PMID: 33846814 DOI: 10.3892/or.2021.8035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Yang R, Liu B, Yang M, Xu F, Wu S, Zhao S. Lumiflavin Reduces Cisplatin Resistance in Cancer Stem-Like Cells of OVCAR-3 Cell Line by Inducing Differentiation. Front Oncol 2022;12:859275. [DOI: 10.3389/fonc.2022.859275] [Reference Citation Analysis]
6 Huang W, Chen L, Zhu K, Wang D. Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin. Cell Death Discov 2021;7:379. [PMID: 34876558 DOI: 10.1038/s41420-021-00715-6] [Reference Citation Analysis]
7 Guo R, Xu Q, Liu L, Liu H, Liu Y, Wei W, Qin Y. Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to DDP by Affecting HSF1/HSP70 Signaling Pathway. J Cancer 2021;12:6081-93. [PMID: 34539881 DOI: 10.7150/jca.62285] [Reference Citation Analysis]
8 Xue B, Li S, Jin X, Liu L. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer. BMC Cancer 2021;21:452. [PMID: 33892654 DOI: 10.1186/s12885-021-08166-z] [Reference Citation Analysis]
9 Liu M, Zhou X, Sun L, Tan S, Liu T, Xiao W, Tang J. Chronic stress induces platinum and Niraparib resistance in mouse models of ovarian cancer. Exp Cell Res 2022;410:112935. [PMID: 34875218 DOI: 10.1016/j.yexcr.2021.112935] [Reference Citation Analysis]
10 Ye M, Lin Y, Pan S, Wang ZW, Zhu X. Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis. Front Oncol 2021;11:745808. [PMID: 34631583 DOI: 10.3389/fonc.2021.745808] [Reference Citation Analysis]